These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22894739)

  • 21. The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.
    Toss A; Grandi G; Cagnacci A; Marcheselli L; Pavesi S; De Matteis E; Razzaboni E; Tomasello C; Cascinu S; Cortesi L
    Oncotarget; 2017 Feb; 8(6):9144-9154. PubMed ID: 27880720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in breast cancer by race and ethnicity: update 2006.
    Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
    CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is surgical management compromised in elderly patients with breast cancer?
    Wanebo HJ; Cole B; Chung M; Vezeridis M; Schepps B; Fulton J; Bland K
    Ann Surg; 1997 May; 225(5):579-86; discussion 586-9. PubMed ID: 9193185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related differences in breast cancer treatment.
    August DA; Rea T; Sondak VK
    Ann Surg Oncol; 1994 Jan; 1(1):45-52. PubMed ID: 7834427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of aging on the early detection, diagnosis, and treatment of breast cancer.
    Siebel MF; Muss HB
    Curr Oncol Rep; 2005 Jan; 7(1):23-30. PubMed ID: 15610683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer prevention: lifestyle changes and chemoprevention.
    Lambrechts S; Decloedt J; Neven P
    Acta Clin Belg; 2011; 66(4):283-92. PubMed ID: 21938984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic algorithm for identification of individuals with hereditary predisposition to breast cancer.
    Hossein R; Houshmand M
    Lik Sprava; 2008; (1-2):103-8. PubMed ID: 18822852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for breast cancer in elderly women.
    Sweeney C; Blair CK; Anderson KE; Lazovich D; Folsom AR
    Am J Epidemiol; 2004 Nov; 160(9):868-75. PubMed ID: 15496539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience.
    Haas JA; Schultz DJ; Peterson ME; Solin LJ
    Cancer J Sci Am; 1998; 4(5):308-15. PubMed ID: 9815295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of older age on breast cancer treatment decisions and outcome.
    Merchant TE; McCormick B; Yahalom J; Borgen P
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):565-70. PubMed ID: 8621279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer in older women.
    Muss HB
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):82-8. PubMed ID: 8614851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
    Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attributable risks for breast cancer in Italy: education, family history and reproductive and hormonal factors.
    Tavani A; Braga C; La Vecchia C; Negri E; Russo A; Franceschi S
    Int J Cancer; 1997 Jan; 70(2):159-63. PubMed ID: 9009154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
    Colditz GA
    J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive factors and familial predisposition for breast cancer by age 50 years. A case-control-family study for assessing main effects and possible gene-environment interaction.
    Becher H; Schmidt S; Chang-Claude J
    Int J Epidemiol; 2003 Feb; 32(1):38-48. PubMed ID: 12690006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
    Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA
    JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding breast cancer risk -- where do we stand in 2005?
    Dumitrescu RG; Cotarla I
    J Cell Mol Med; 2005; 9(1):208-21. PubMed ID: 15784178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.